Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT5 | Q11128 | 1/20 | 0.49 |
| ▸ | TGM2 | P21980 | 1/20 | 0.48 |
| ▸ | KRAS | P01116 | 3/20 | 0.46 |
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
| ▸ | RNASEL | Q05823 | 5/20 | 0.44 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.44 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.44 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.44 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.44 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.41 |
| ▸ | FUT6 | P51993 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29313131 | 0.98 | FUT5 (0.52) | FUT5TGM2KRASNT5ERNASEL | |
| SCHEMBL29313147 | 0.89 | FUT5 (0.58) | FUT5TGM2KRASNT5EP2RY2 | |
| SCHEMBL20763738 | 0.88 | RNASEL (0.57) | FUT5TGM2KRASNT5ERNASEL | |
| SCHEMBL22678645 | 0.88 | RNASEL (0.57) | FUT5TGM2KRASNT5ERNASEL | |
| SCHEMBL20763533 | 0.83 | TGM2 (0.61) | FUT5TGM2KRASNT5ERNASEL | |
| SCHEMBL18769124 | 0.83 | TGM2 (0.63) | FUT5TGM2KRASNT5EP2RY2 | |
| SCHEMBL26535515 | 0.83 | TGM2 (0.53) | FUT5TGM2KRASNT5ERNASEL | |
| SCHEMBL29313140 | 0.83 | TGM2 (0.56) | FUT5TGM2KRASNT5EP2RY2 | |
| SCHEMBL18763211 | 0.82 | FUT5 (0.68) | FUT5TGM2KRASNT5EP2RY2 | |
| SCHEMBL22388612 | 0.81 | FUT5 (0.58) | FUT5TGM2KRASNT5EP2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226132-A1 | RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME | BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226132-A1 | RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME | SNRPB2, NSUN2, RNMT | FUT5 2732/4885TGM2 3338/4885KRAS 840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.